Form 4: Nutex Health CEO Acquires 5,000 Shares Through Indirect Ownership

Nutex Health CEO, Thomas T. Vo, indirectly acquired 5,000 shares of common stock on January 8, 2025, through entities he controls.

Summary

• Thomas T. Vo, the CEO of Nutex Health, Inc., has reported an acquisition of 5,000 shares of common stock.
• The transaction occurred on January 8, 2025.
• The shares were acquired indirectly through entities controlled by Mr. Vo.
• The acquisition price was $0, indicating a grant or similar transaction.
• Following the transaction, Mr. Vo's indirect ownership totals 1,833,774 shares.
• This includes 1,809,860 shares held by Micro Hospital Holding LLC and 23,914 shares held by Vo Family Limited Partnership.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of an insider transaction, with no inherent positive or negative sentiment.

Industry Context

This is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the ownership changes of key executives.

Comparison to Industry Standards

• SEC Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders across all publicly traded companies.
• The reporting requirements are consistent across the industry, ensuring transparency and preventing insider trading.

Stakeholder Impact

• This transaction provides transparency to shareholders regarding the CEO's ownership stake in the company.

Key Dates

Keywords

Nutex Health, Thomas T. Vo, insider trading, share acquisition, common stock, indirect ownership, SEC Form 4